CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 518,318 |
| 2026-03-17 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.40 | $255K | 499,258 |
| 2026-03-17 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 33,383 | ||
| 2026-03-16 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 522,656 |
| 2026-03-16 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.41 | $256K | 503,596 |
| 2026-03-16 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 48,105 | ||
| 2026-03-13 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 526,994 |
| 2026-03-13 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $12.96 | $247K | 507,934 |
| 2026-03-13 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 62,827 | ||
| 2026-03-12 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 531,332 |
| 2026-03-12 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −13,660 | $12.63 | $173K | 517,672 |
| 2026-03-12 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,400 | $13.43 | $73K | 512,272 |
| 2026-03-12 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 77,549 | ||
| 2026-03-11 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | −41,338 | $13.17 | $544K | 427,775 |
| 2026-03-11 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale | −63,103 | $13.17 | $831K | 272,751 |
| 2026-03-11 | ROBINS HARLAN S Chief Scientific Officer | Sale | −140,666 | $13.17 | $1.9M | 1,851,658 |
| 2026-03-11 | ROBINS HARLAN S Chief Scientific Officer | Sale | −329,600 | $13.17 | $4.3M | 1,522,058 |
| 2026-03-11 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −122,523 | $13.17 | $1.6M | 520,948 |
| 2026-03-11 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $6.55 | $96K | 535,670 |
| 2026-03-11 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.08 | $268K | 516,610 |
Page 17 of 119 · 2,375 trades